Cargando…
The Sulforaphane and pyridoxamine supplementation normalize endothelial dysfunction associated with type 2 diabetes
In this study we investigate pyridoxamine (PM) and/or sulforaphane (SFN) as therapeutic interventions to determine whether activators of NFE2-related factor 2 (Nrf2) can be used in addition with inhibitors of advanced glycation end products (AGE) formation to attenuate oxidative stress and improve e...
Autores principales: | Pereira, Ana, Fernandes, Rosa, Crisóstomo, Joana, Seiça, Raquel M., Sena, Cristina M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5662716/ https://www.ncbi.nlm.nih.gov/pubmed/29085055 http://dx.doi.org/10.1038/s41598-017-14733-x |
Ejemplares similares
-
Reduction of Methylglyoxal-Induced Glycation by Pyridoxamine
Improves Adipose Tissue Microvascular Lesions
por: Rodrigues, Tiago, et al.
Publicado: (2013) -
Cinnamaldehyde Supplementation Reverts Endothelial Dysfunction in Rat Models of Diet-Induced Obesity: Role of NF-E2-Related Factor-2
por: Sena, Cristina M., et al.
Publicado: (2022) -
Protective Effects of Pyridoxamine Supplementation in the Early Stages of Diet-Induced Kidney Dysfunction
por: Chiazza, F., et al.
Publicado: (2017) -
Cognitive dysfunction in diabetic rats is prevented by pyridoxamine treatment. A multidisciplinary investigation
por: Kassab, Sarah, et al.
Publicado: (2019) -
Preventive Effect of Salicylate and Pyridoxamine on Diabetic Nephropathy
por: Abouzed, Tarek Kamal, et al.
Publicado: (2016)